Enanta Pharmaceuticals Doses First Patient in Zelicapavir Phase 2b/3 Study
The global study will evaluate symptom duration and hospitalization rates in adult outpatients with respiratory syncytial virus.
The global study will evaluate symptom duration and hospitalization rates in adult outpatients with respiratory syncytial virus.